Current Advances in the Translation of Vascular Tissue Engineering to the Treatment of Pediatric Congenital Heart Disease

Tissue-engineered vascular grafts (TEVGs) hold great promise for the improvement of outcomes in pediatric patients with congenital cardiac anomalies. Currently used synthetic grafts have several limitations, including thrombogenicity, increased risk of infection, and lack of growth potential. The fi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Dean, Ethan W., Udelsman, Brooks, Breuer, Christopher K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: YJBM 2012
Gaiak:
Focus: Biomedical Engineering
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3375656/
https://ncbi.nlm.nih.gov/pubmed/22737051
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak